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Polymeric micelles (PMs) have been the most popular and 
promising topic of many researches in the field of drug delivery and 
targeting for the past two decades. Polymeric micelles are the self-
assembled nano-sized colloidal particles which are made up of 
amphiphilic block copolymers i.e. polymers consisting of hydro-
phobic block and hydrophilic block. In this highlight, we give an 
overview of the structure of micelles and polymeric micelles followed 
by a summary of the methods used for their preparation. We then 
focus on several kinds of PMs based on intermolecular forces such as 
polyion complex micelles (PICMs), non-covalently connected 
micelles (NCCMs) and recently developed smart polymeric 
assemblies which can respond to the application of external stimuli 
such as a change in temperature, pH, redox and light to afford novel 
nanomaterials. The types of polymers used in the preparation of PMs 
have also been highlighted so as to facilitate its use in drug delivery 
and targeting. These polymeric micelles nanocarriers have 
applications in drug delivery primarily such as anticancer therapy, to 
the brain to treat neurodegenerative diseases, antifungal agents, 
stimuli-responsive nanocarriers for drug and gene delivery, ocular 
drug delivery. Targeted drugs will hopefully reduce adverse 
reactions by limiting their action to cancer tissue only. Finally, this 
review broadly presents the basic aspects of PMs which help in 
delivery and targeting of actives with its recent advancements and 
applications.  
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INTRODUCTION 
There has been a progressively 
increasing attention and demand for 
development of drug delivery systems which 
are not only highly efficient but also site- 
specific (Scholz et al., 1998). Colloidal 
nanocarriers including nanoparticles, micelles 
and liposome are one of the drug delivery 
system which fulfills the criteria of site 
specificity and targeting. Polymeric  Micelles 
(PMs) are particulate colloidal carrier system 
which get self-assembles in aqueous media and 
are made up of linear amphiphilic 
macromolecules possessing both hydrophilic 
‘blocks’ and hydrophobic ‘blocks’ (AB-type) on 
a single strand (each copolymer strand is 
amphiphilic). These polymeric micelles 
possesses the particle sizes range between 10–
100 nm which making them considerably 
smaller than phospholipids vesicles (liposomes) 
(Trubetskoy, 1999). In addition to being safe 
these drug delivery system must possess high 
loading capacity, extended circulation time and 
accumulation in the required pathological sites 
(Moghimi et al., 2001, Couvreur and Vauthier, 
2006).  
Basically, two primary factors which 
influence the efficacy of drug delivery system 
by block copolymer aggregates are temporal 
and distribution controls. The former term 
refers to the time required and the process to 
release the drug molecules from the inside of 
micelle core to the target and the later term is 
associated with the drug molecules which get 
distributed to the target site and accumulated in 
these special regions without getting lost in 
other parts of the circulation system. Recently, 
polymeric micelles have been attracted because 
of increased attention as a promising vehicle 
for poorly soluble drugs (Rosler et al., 2001., 
Wang et al., 2008). 
 
Micelles 
Surfactants play a major role in many 
processes of interest in both fundamental and 
applied science. The construction  of  colloidal- 
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sized clusters in solutions is one of the most 
important uniqueness of surfactants which is 
termed as micelles. These micelles possess 
particular significance in pharmaceutical field 
because of their capability to increase the 
solubility of sparingly soluble substances in 
water. Formation of micelles takes place when 
surfactant molecules are dissolved in water at 
concentrations above the critical micelle 
concentration (CMC) (Mall et al., 1996). CMC is 
defined as the concentration of surfactants 
above which micelles form and almost all 
additional surfactants added to the system go to 
micelles (Allen et al., 1999).  
Micelles consist of amphiphiles or 
surface-active agents i.e. surfactants, which 
have two different parts: a hydrophilic head-
part and a hydrophobic tail part (Dhembre et 
al., 2011). The radius of a spherical micelle is 
almost  same  as the length of  a fully  extended  
surfactant monomer i.e. 1-3 nm and thus, 
micelle lie in the colloidal range (Mourya et al., 
2011). Micelles are unstable or labile colloidal 
clusters, formed when the several individual 
surfactant monomers are aggregated by 
noncovalent bond. Therefore, micelles may be 
spherical, cylindrical, or planar (discs or 
bilayers) as shown in figure 1. The shape and 
size of micelles can be controlled by changing 
the surfactant chemical structure as well as by 
varying solution conditions such as 
temperature, composition of surfactant, 
concentration of surfactants, ionic strength and 
pH (Yagui et al., 2005). Depending on the 
targeting site, one can select the size, charge, 
and surface properties of these carriers by 
adding new ingredients to the mixture of 
amphiphilic substances before micelle 
preparation and/or by variation of the 
preparation method (Yokoyama et al., 1990., 
Lee and Yamamoto, 1990., Torchilin, 2001).  
The key driving force behind self-
association of amphiphilic molecules is the 
decrease in free energy of the system and this 
decrease in free energy is a result of removal  of  
hydrophobic fragments from the aqueous 
surroundings with the formation of a micelle 
core    stabilized   with   hydrophilic   fragments 
 
A- Hydrophilic block copolymer          B- Hydrophobic block copolymer 
 




  Figure 2. Structure of polymeric micelle 
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exposed into water (Mourya et al., 2011). The 
major advantage of Micelles is its ability to 
solubilize poorly soluble drugs. Once its 
solubility get increased, the absorption of drug 
in body will also be enhanced which results in 
increased bioavailability. Another interesting 
fact about micelle is to its small size which 
allows them to accumulate in areas which have 
leaky vasculature and can circulate long enough 
in the body (Torchilin, 2001). 
 
Polymeric micelles 
Polymeric micelles are nano-sized 
colloidal carrier system which comprise of 
polymer chains. These are spontaneously 
formed by self-assembly in a liquid, generally as 
a result of hydrophobic or ion pair interactions 
between polymer segments. Micelles usually 
have a core-shell structure, in which core 
contains either the hydrophobic part or the 
ionic part of the nanoparticles, and can posses 
either small or bigger molecules such as 
therapeutic active drugs, while the shell 
provides interactions with the solvent and 
construct the nanoparticles which is stable in 
the liquid (Nostrum and Cornelus, 2012), the 
structure is shown in figure 2.  
Polymeric micelles are formed from 
amphiphilic block copolymers which comprises 
of both hydrophilic and hydrophobic monomer 
units, such as PEO and PPO (polypropylene 
oxide), respectively. A schematic diagram of the 
formation of micelles from an amphiphilic 
molecule and the loading of hydrophobic drugs 
are shown in figure 3. With the length of the 
hydrophilic, block exceeding the length of the 
hydrophobic block and these amphiphilic block 
co-polymers can form spherical micelles in 
 
 





Figure 4. Flowchart illustrated various types of polymeric nanoassemblies 
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aqueous solution (Kwon and Katarka, 1995). 
Polymeric micelles possess the following 
characteristic such as water solubility, lack of 
long-term accumulation in host, non-toxicity, 
non-immunogenicity, in vivo stability and 
selective delivery to the target site for valuable 
drug delivery (Adams et al., 2003).  
There are a few factors which control 
the size of the polymeric micelles which include 
molecular weight of the amphiphilic block 
copolymer, relative proportion of hydrophilic 
and hydrophobic chains, aggregation number 
of the amphiphiles, and the preparation process 
(Jones and Heroux, 1999). Moreover, polymeric 
micelles are generally much more superior to 
the surfactant micelles by exhibiting slower 
dissociation rates, lower critical micelle 
concentrations (CMCs), and longer retention of 
loaded therapeutic drugs (Torchilin, 2002). 
Polymeric micelles may lead to the 
development of 'intelligent vesicles' by the use 
of stimuli-sensitive polymers i.e. pH or 
temperature sensitive copolymers. Such 
intelligent vesicles are at present being explored 
for achieving controlled drug release (Otsuka et 
al., 2003). Polymeric micelles provide a 
powerful multifunctional platform for the 
delivery of therapeutic drugs and diagnostic 
imaging applications (Ai et al., 2005). Because of 
the multifunctional nature of polymeric 
micelles, it appears to fulfill a number of tasks 
essential for an ideal carrier capable of selective 
drug delivery at different levels (Li et al., 1999., 
Kataoka et al., 1993., Klaikherd et al., 2009).  
 
TYPES OF POLYMERIC MICELLES 
Several types of polymeric assemblies are 
fabricated for drug delivery at the target sites. 
These are illustrated in the form of flowchart in 
figure 4 and discussed below in detail. 
 
Amphiphilic copolymers based assemblies 
Most of the polymeric micelles used for 
drug delivery and targeting are fabricated by 
amphiphilic copolymers, in which one or more 
hydrophobic blocks are covalently linked with 
one or more hydrophilic parts. It can be seen 
that various polyesters are widely engaged as 
hydrophobic blocks which including 
polylactide(PLA), poly (lactide-co-glycolide) 
(PLGA), poly (lactide-co-caprolactone), poly (p-
dioxanone), poly (p-dioxanone-co-lactide), and 
polyorthoester. Water soluble polymers 
including polyalkylene glycols, polyvinyl alcohol 
(PVA), polyN-(2- hydroxypropyl) methacryla-
mide (PHPMA), poly (N-vinylpyrrolidone) 
(PVP), poly (acrylic acid) and polyacrylamides 
are widely employed as hydrophilic block 
(Zhanga et al., 2009).  
For hydrophobic compounds, 
amphiphilic copolymers based assemblies are 
most suitable carriers. An amphiphilic block 
copolymer of PEG-b-poly (aspartic acid) 
chemically conjugated with Dox is the micelles 
preparation which is intensively studied in 
Kataoka’s lab. This polymeric micelle can 
efficiently entrap free Dox in the inner core, 
and the augmented preparation called NK911 
which is now under a phase II clinical 
assessment (Matsumura et al., 2004). 
 
Hydrophilic copolymers based assemblies 
Kataoka et al reported the first drug 
delivery system fabricated by a hydrophilic 
copolymer and drug molecule ‘Cisplatin’, an 
anticancer drug which interacts with a 
hydrophilic block copolymer of PEG-b-poly 
(aspartic acid) to form nano-assemblies via the 
metal ligand coordination between platinum 
and carboxylic acid groups (Yokoyama et al., 
1996). Currently, host-guest interactions have 
been implemented to make core-shell nano-
assemblies via a double hydrophilic copolymer 
with one β cyclodextrin (β-CD) and another 
containing PEG block wherein hydrophobic 
compounds (either polymers or small 
molecules) served as the guest molecules. For 
hydrophobic drugs, this kind of host-guest 
assemblies can be used as delivery vehicles 
(Zhang et al., 2009). 
 
Stimuli responsive or stimuli sensitive 
or smart polymer assemblies 
Polymer assemblies have been        
proposed to have potential as delivery vehicles                     
for controlled encapsulation and release. To 
efficiently accomplish this, it is essential that 
the polymer vesicles should respond to the 
external stimuli such as a change in pH, 
oxidation/reduction, light, temperature etc. 
This  external  stimulus  permits the   prompted 
release of a payload or the selective uptake of a 
payload, which modifies the assembly (Du et al., 
2009).  
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Destabilization of micelles as a 
consequence of stimulation by either 
physiological or external trigger is termed as 
'stimuli-sensitivity' or 'environmental sensitivity' 
of the micelles (Zhang et al., 2006).  
 
Thermo-responsive assemblies 
Polymers which are responsive to 
temperature changes are the most studied class 
of external stimuli sensitive polymers (Gil and 
Hudson, 2004). As the temperature increases, 
the thermo responsive micelles undergo a 
structural change which results in the 
deposition of the drug and easier drug 
absorption by cells (Zhang et al., 2002). A 
thermo-sensitive polymer shows a lower 
Critical Solution Temperature  (LCST)  in  
aqueous solution. Lower critical solution 
temperature (LCST) is defined concisely as the 
phase transition temperature of a thermo-
sensitive polymer below which the polymers 
are water soluble and above which they become 
water insoluble. Thermo-responsive polymeric 
micelles can be fabricated by the self assembly 
of a thermo- responsive block polymer and 
hydrophobic block polymer. The outer shell of 
this polymeric micelle acquires the property of 
thermo-sensitivity and plays the role of aqueous 
solubilization while the hydrophobic inner core 
is loaded with the water-insoluble drugs. For 
instance, thermo responsive  part of poly (N-
isopropylacrylamide-co-N,N-dimethylacrylamide) 
[P (NIPAM-co- DMAAm)] and hydrophobic 
part of poly (D,L-lactide) were prepared by a 
combination of reversible addition–
fragmentation chain-transfer (RAFT) and ring-
opening polymerization. The thermo-
responsive    micelles   obtained    from    these  
polymers were approximately 25nm when 
below the LCST of 40°C, and their sizes get 
increased to an average of approximately 
600nm above the LCST due to aggregation of 
the micelles (Akimoto et al., 2009). 
 
pH-responsive or acid sensitive assemblies 
pH-sensitive polymeric assemblies are 
those in which polymer contain weak acidic or 
basic groups in the block copolymer at 
different pH, which either accept or release 
protons in response to changes in 
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environmental pH (Du et al., 2009).  For 
instances pH sensitive polymers with anionic 
groups are poly (carboxylic acid) or poly (acrylic 
acid) (PAA) or poly (methacrylic acid). 
Polysulfonamides (derivatives of p-aminoben-
zenesulfonamide) are the another kind of 
polyacidic polymer and poly (N,N-diakyl-
aminoethylmethacrylates), poly(lysine) (PL), 
poly (ethylenimine) (PEI) and chitosan are   
few  examples  of  cationic polyelectrolyte. pH-
sensitive polymers have been used in several 
biomedical applications, the most important 
being their use as drug and gene delivery 
systems, and glucose sensors (Aguilar et al., 
2007).  Both block copolymers and synthetic 
block copolypeptides have been used to make 
pH-responsive polymer vesicles or micelles (Du 
et al., 2009) 
Licciardi et al. (2005) prepared the 
tumor-targeting polymeric micelles by using the 
folic acid (FA)-functionalized diblock 
copolymers consisting (MPC) 2-(methacryloy-
loxy)-ethyl phosphorylcholine and either 2-
(dimethyl-amino) ethyl methacrylate (DMA) or 
2-(diisopropylamino) ethyl methacrylate (DPA). 
These diblock copolymers are good candidates 
for drug delivery and gene therapy because of 




There is a significant concern in the 
preparation of polymeric assemblies which 
respond to a change in redox environment. 
Polymeric micelles with a redox-responsive 
property have attracted researchers in recent 
years (Du et al., 2009). Sun et al. prepared a new 
category of shell-sheddable micelle based on 
the biodegradable disulfide linked dextran-b-
poly (ε-caprolactone) diblock copolymer (Dex-
SS-PCL) by using doxorubicin (DOX) for 
intracellular drug delivery. It is well known that 
the disulfide bond breaks in the presence of a 
reducing agent. Without the reducing agent 
polymeric micelles are stable for a long         
time, whereas they will undergo a fast        
shedding process when subjected to reduction 
conditions (glutathione (GSH), at a higher level 
in a cancer cell than that in a normal cell in vivo), 
which was confirmed by the diverse changes in 
size and rapid drug release. Thus these 
reduction-responsive biodegradable micelles 
have appeared highly promising for the targeted 
intracellular delivery of hydrophobic chemo-
therapeutics in cancer therapy (Sun et al., 2010).  
 
Light responsive polymeric assemblies 
In comparison to pH- or redox 
responsive polymeric assemblies, light 
responsive assemblies proposed the advantage, 
that no extra chemical additives are mandatory 
to induce the response in the controlled release 
of encapsulated molecules (Zhanga et al., 2009).   
To trigger the release of drug from the 
polymeric micelles, ultraviolet (UV) and near 
infrared (NIR) light can be used. UV light is 
not able to penetrate deeply into the body 
because it get absorb by the skin so it can be 
utilizes to trigger the drug release from topical 
preparation of polymeric micelles. NIR is able 
to penetrate deeply into the body because 
hemoglobin, water and lipids have low 
absorption in the NIR region (650–900 nm) 
(Oerlemans et al., 2010).  
The main basic concept for the 
preparation of light-responsive polymer 
assembly is to introduce a chromophore like 
liquid crystalline azobenzenes (LC-Azo) into 
the structure of the hydrophobic block, whose 
photoreaction can result in a conformational or 
structural change. However, these azobenzene-
based polymer self-assemblies cannot be 
completely demolished by light. The principle 
of light-changeable or light-switchable 
amphiphilicity may be extended to many 
polymer/chromophore combinations. For 
example, spirabenzopyran can form a zwitter 
ionic species and triphenyl methane 
leucohydroxide can produce charges upon light 
irradiation to afford a hydrophobicity change 
(Zhanga et al., 2009).  
Liu et al. (2012) prepared the near-
infrared light-sensitive polymeric micelles for 
the enhanced intracellular delivery of 
doxorubicin (DOX), an anticancer drug. These 
micelles were prepared from dextran-graft-(2-
diazo-1,2-naphthoquin-one)(Dex-DNQ) amphi-
philic copolymers which were synthesized by 
modification of hydrophilic dextran with 
hydrophobic DNQ molecules. The hydro-
phobic DNQ molecule is an attractive photo-
trigger group. Thus Dex-DNQ micelles will 
promptly release encapsulated drugs due to the 
micelle dissociation under UV or NIR 
Potential Drug Delivery Devices 
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irradiation.  This smart drug nanocarrier is 
potentially  useful for cancer chemotherapy 
(Liu et al., 2012). 
 
Based on type of intermolecular forces 
On the basis of type of intermolecular 
forces, polymeric micelles can be classified in 
two main categories. Intermolecular forces 
including hydrophobic, steric, electrostatic, 
hydrogen bonding, and van der Waals 
interactions which control the separation of the 
core segment from the aqueous environment. 
Following are the two main categories: 
polyion complex micelles; Noncovalently 
Connected Polymeric Micelles (Mourya et al., 
2011); Polyion Complex Micelles. 
Polyion complex (PIC) micelles are 
made up of two block copolymers with 
opposite charges. The formation of PIC 
micelles was first proposed by Harada and 
Kataoka (Harada and Kataoka, 1997). The 
assemblies which are formed via electrostatic 
forces by block copolymers contain at least one 
ionic block , one non-ionic block and ionic 
polymers with charge opposite to that of the 
copolymers, are known as polyion complex 
(PIC) micelles or polyelectrolyte. These 
assemblies have been widely studied for gene 
delivery recently (Nishiyama and Kataoka, 
2006). The sizes of PICMs were about 50 to 
200 nm and the loading efficiency of micelle 
was higher than 80% (w/w) (Jeong et al., 2006). 
PICMs have some unique characteristics such 
as simple synthetic route, easy self-assembly in 
aqueous medium, structural stability, high drug 
loading capacity, and prolonged circulation in 
the blood. Thus, one can find the  application 
of PICMs  for  the delivery of charged drugs 
along with antisense oligonucleotides, DNA, 
and enzymes (Ranger et al., 2001, Zhang et al., 
2009).  
 
Noncovalently Connected Polymeric Micelles 
(NCCMs) 
The core and shell forming components are 
connected by hydrogen bonding instead of the 
normal covalent bonding that exists in all 
micelles formed from block copolymers. The 
field of NCCM has been significantly 
broadened by the introduction of host–guest 
interactions as new driving forces. The 
enormous accumulation of knowledge and data 
of host–guest interactions in supramolecular 
chemistry offers a productive basis for the 
further developments of NCCMs (Guo and 
Jian, 2009). Jiang et al. synthesized the 
intermolecular complexes with poly (4-
vinylpyridine) as the backbone and carboxyl 
terminated polybutadiene as the grafts in a 
common solvent, chloroform due to hydrogen 
bonding (Wang et al., 2001) 
 
TYPES OF POLYMER OR COPOLYMER 
USED IN POLYMERIC MICELLES 
FABRICATION 
Polymeric micelles are usually made up 
of two types of polymers i.e. :Block copoly-
mers; Graft copolymers; Block copolymers. 
These are generally linear polymers that 
are composed of a sequence of at least two 
polymer parts that differ in aspect of physico-
chemical properties, e.g. charge and/or polarity. 
Block copolymers can be categorized according 
to their architecture as AB-type diblock, ABA- 
or BAB-type triblock, and multiblock, where A 
represents the soluble block in a selected 
solvent and B describes the insoluble block. 
Different types of block copolymers are shown 
in figure 5. 
In the simplest case, a diblock copolymer 
AB consists of two different homopolymers 
linked end to end. Addition of this concept 
leads to ABA or BAB triblocks and to (AB)n 
linear multiblocks, whereas ABC copolymers 
are gained by the incorporation of a          
polymer sequence having a third composition. 
Examples of such block  copolymer s are  PS–
poly (diene) di- and triblock, PPO–PEO as 
hydrophilic–hydrophobic copolymers, acrylic 
copolymers and many others (Qiu and Bae, 
2006).  
Reversible addition fragmentation chain 
transfer (RAFT) polymerization, atom transfer 
radical polymerization (ATRP) are the two 
controlled radical polymerization (CRP) 
techniques which are used in the synthesis of 
most of block copolymers used in self-assembly 
of the polymeric micelles. Among them,   
ATRP is one of the most prevailing and 
adaptable CRP technique. It enables precise 
control over molecular weight, molecular 
weight distribution, and functionality (Siegwart 
et al., 2012).  
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Graft copolymers 
In graft copolymers, side chain parts are 
grafted to a main polymer chain. Fully 
hydrophilic block or graft copolymers in which 
one of the parts carry a charge which may form 
stable complexes in water together with 
oppositely charged (macro) molecules, for 
instance-polyion complex micelles or 
polyelectrolyte micelles (Qiu and Bae, 2006). In 
the formation of polymeric micelles, Graft 
copolymers have some advantages over block 
copolymers i.e. they contain multi-grafted 
hydrophobic polymer chains along a 
hydrophilic polymer backbone. The delicate 
hydrophilic/ hydrophobic balance in a graft 
copolymer structure can be readily controlled 
by changing the relative grafting density 
between the grafted hydrophobic polymer and 
the hydrophilic back bone polymer (Jeong et al., 
2003).  Table I shows different possible struc-
tures of micelle forming copolymers with 
representtative example of each class (Mourya 
et al., 2011). 
 
Some commercially used polymers  
Various polymers can be used for the 
formation of polymeric micelles with variations 
in the hydrophilic and hydrophobic blocks 
generating for possible drug delivery vehicles. 
These PMs plays a significant role for 
delivering and targeting a therapeutic drug to 
the body and then digested by the body. 
Polymers that are used in the formation of 
polymeric micelles must be an FDA approved 
devices; these requirements limit the choice for 
the various blocks. Poly (ethylene glycol) 
(PEG) is most commonly used polymer 
because it is inexpensive and has low toxicity. 
PEG is a non biodegradable in nature, due to 
which it is easily removed from the               
body through the excretion pathway if under             
a mol.wt. of 15 kDa (Karine et al., 2008). 
Another polymer that are widely used is poly 
(N-vinyl-2-pyrrolidone) (PVP), which is 
repeatedly considered as a primary alternative 
to PEG. Similar to PEG, this polymer is          
highly biocompatible and was used in 
preparation of such particulate drug  carriers  as 
liposomes, nanoparticles, microspheres and 
diblock polymer micelles (Torchilin, 2007). 
From the currently disclosed patents, it can              
be seen that polyesters, including polylactide 
(PLA),     poly   (lactide-co-glycolide)   (PLGA),  
poly (Ɛ-caprolactone) (PCL), poly (lactide-co-
caprolactone), poly(p-dioxanone), poly(p-
dioxanone-co-lactide), poly(p-dioxanone-
cocaprolactone), poly(3-hydroxybutyrate), and 
polyorthoester, are widely employed 
hydrophobic blocks. Other biodegradable 
polymers such as polyanhydride, derivatives of 
poly(amino acid) and non-degradable polymers 
like poly(alkylacrylate) are also patented 
hydrophobic segments (Zhanga et al., 2009). 
A list of different polymers/copolymers 
used to prepare micelles loaded with various 
pharmaceuticals is shown in table II. 
Table I. Structures of micelle-forming copolymer 
Type of micelle forming 
copolymers         












Block copolymers Poly(styrene)-b-poly(ethylene oxide) 
Poly(ethylene oxide)-b-poly 
(propylene oxide) -b-poly (ethylene 
oxide) 
di – block 
AAAAAAABBBBBB 
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ADVANTAGES OF POLYMERIC 
MICELLES 
Polymeric micelles posses some 
advantages in pharmaceutical field which are 
describe as follows. High structural stability is 
the first advantage of polymeric micelles. 
Polymeric micelles retain high structural 
stability provided by the entanglement of 
polymer chains in the inner core. The high 
structural stability of polymeric micelles is an 
important key to in vivo delivery in micellar 
forms and simultaneously eliminates the 
possible contribution of single polymer chains 
to drug delivery.  
The second main advantage is the very 
small size of polymeric micelle. Polymeric 
micelles have a diameter range from 10nm to 
100nm which is considered ideal for the 
achievement of stable, long-term circulation of 
the carrier system in the bloodstream. 
Alternatively, the small size of polymeric 
micelles posses a greater advantage in the 
sterilization processes in pharmaceutical 
productions. Hence polymeric micelles are 
basically free of micro-sized particle’s 
contamination.  
The third advantage of the polymeric 
micelle is its high water solubility. Polymeric 
micelles can incorporate a large number of 
hydrophobic drug molecules in the micelles’ 
inner core, and simultaneously, the micelles 
may maintain their water solubility by inhibiting 
inter micellar aggregation of the hydrophobic 
cores with a hydrophilic outer shell layer that 
works as a barrier against inter micellar 
aggregation.  
The fourth advantage of polymeric 
micelles is that a range of chemical species can 
be incorporated into polymeric micelles. These 
drugs can be incorporated into the micelle 
inner core either by chemical conjugation to the 
inner-core-forming polymer block or by 
physical entrapment owing to hydrophobic 
interactions between the entrapped drug 
molecules and the hydrophobic inner-core 
forming polymer block. Low toxicity is the fifth 
advantage of the polymeric micelles. Generally, 
polymeric surfactants are known to be less 
toxic than low-molecular-weight surfactants, 
such as sodium dodecyl sulfate.  
 
 
DISADVANTAGES OF POLYMERIC 
MICELLE AS A DRUG CARRIER 
Everything in this world has positive and 
negative aspects so polymeric micelles have also 
some negative aspects which are describe as 
follows. The first negative aspect of polymeric 
micelles is that relatively high levels of polymer 
chemistry are needed in the polymeric micelle 
studies. The second negative aspect for the 
polymeric micelle systems is the immature 
technology for drug incorporation in a physical 
manner. Yokoyama et al., reported that physical 
incorporation efficiencies were dependent on 
various factors in drug-incorporation processes. 
Presently, there seem to be no universal 
incorporation method applicable to any 
polymer. The third negative aspect is much 
slower extravasations of polymeric carrier 
systems than that of low-molecular weight 
drugs. This outcome from a difference in 
extravasation mechanisms between low 
molecular-weight drugs and polymeric carrier 
systems (Yokoyama, 2011). 
 
METHODS OF PREPARATION OF 
POLYMERIC MICELLES 
By using the self-assembly of block 
copolymers there are two general methods for 
the preparation of polymeric micelles. One is 
the direct dissolution method or the organic-
solvent-free method and the other is the 
solvent evaporation or solution-casting 
technique or ‘solvent-switch’ method 
 
The organic-solvent-free method or 
direct dissolution method 
In this method for the dissolution of the 
block copolymer only water is mandatory to 
allow for self-assembly. It involves direct 
dissolution of the amphiphilic copolymer and 
drug in water for preparing drug-loaded 
polymeric micelles. But low drug loading is the 
disadvantage of this method so to enhance 
drug loading, this technique can be combined 
with an increase in temperature or alternately 
before the addition of copolymer, a thin   
evaporated  film of drug can be prepared. Du 
and Armes recently reported the direct 
dissolution of poly(3-caprolactone)-b-poly(2-
aminoethyl   methacrylate)  [PCL-b-PAMA]  or  
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poly(3-caprolactone)-b-poly[2-(methacryloyl-
oxy) ethyl phosphorylcholine] [PCL-b-PMPC] 
block copolymers in pure water without the 
need of organic solvent. 
 
Solvent evaporation or solution-casting 
method 
In this method, a volatile organic solvent 
is employed to dissolve the block copolymer 
and the drug because most amphiphilic block 
copolymers are not directly soluble in water. A 
thin film of copolymer and drug is obtained 
after the solvent is removed by evaporation. 
Drug-loaded polymeric micelles are obtained by 
reconstitution of film with water. But when the 
core forming blocks are long and more 
hydrophobic, the two above-mentioned 
techniques are unsuitable. Micelles from such 
copolymers have more potential to solubilize 
large amounts of poorly water-soluble drugs 
(Mourya et al., 2011, Du et al., 2009).  
 
APPLICATION OF POLYMERIC 
MICELLES 
The studies on the application of PMs in 
drug delivery and drug targeting have mostly 
focused on the following areas that are 
considered below 
 
Drug delivery to the brain 
Presence of blood–brain barrier (BBB) is 
the major obstacle in drug delivery to the brain 
and neurodegenerative diseases such as 
Parkinson's and Alzheimer's diseases because it 
limits the drug penetration even if in certain 
pathological situations the BBB is partly 
disrupted (Garcia et al., 2005). A schematic 
representation of different mechanisms used to 
cross the BBB is shown in figure 6. Two 
approaches have been used by polymeric 
micelles to improve the delivery of therapeutic 
drugs to brain. The first approach is proposed 
on the basis of the modification of polymer 
micelles with antibodies or ligand molecules 
capable of transcytosis across brain microvessel 
endothelial cells, comprising the BBB. The 
second approach uses Pluronic block 
copolymers to hinder drug efflux systems, 
particularly, Pgp, and selectively augment the 
permeability of BBB to Pgp substrates 
(Dhembre et al., 2011). Kabanov et al. have 
demonstrated that poloxamer (PluronicTM) 
micelles conjugated with antibodies may 
improve brain distribution of haloperidol which 
is a neuroleptic agent; this approach has 
resulted in a dramatic improvement of drug 
efficacy. This result specifies that PluronicTM 
micelles offer an effective transport of 
solubilized neuroleptic agents across the BBB 
(Kabanov et al., 1992). Recent investigations 
made by the same group revealed that only 
PluronicTM unimers allowed cell penetration in 
bovine mammary epithelial cells (BMEC) 
monolayer of molecules such as rhodamine, 
digoxin or doxorubicin by inhibition of the P-
gp mediated drug efflux system (Batrakova et 
al., 2001, Miller et al., 2001 and Alakhov et al., 
1999). 
 
Ocular drug delivery 
Eye remains a challenging task for the 
efficient drug delivery to the pharmaceutical 
scientists due to the several anatomical barriers 
and the clearance mechanisms prevailing in the 
eye. Conventional drug delivery systems, such 
as eye drop solutions, suffer from low 
bioavailability. More invasive methods, such as 
intravitreal injections and implants, cause 
adverse effects in the eye. Recently, an 
increasing number of scientists have turned to 
nanomaterial based drug delivery systems to 
address the challenges faced by conventional 
methods (Liu, 2012). For topical ophthalmic 
application, micro and nanoparticles are 
presently being researched based on 
nanotechnology in which drugs can be 
administered as an eye drop. Poorly water 
soluble or insoluble drugs can be successfully 
fabricated as valuable systems to provide easy 
administration to ocular tissues and 
convenience to the patient for adjustment of 
dose and dosing frequency according to disease 
therapy. Biodegradable polymers can be 
combined with drugs successfully in such a 
approach that the drug is released into the eye 
in a very accurate and controlled manner. 
Nanoparticle formulations provide protection 
for agents liable to degradation or denaturation 
in region of harsh pH, and also prolong the 
duration of exposure of a new drug by 
increasing retention of the formulation through 
bioadhesion. In this context, more clinical 
studies are necessary to provide further 
information and insight into this new 
Upendra Nagaich 
Volume 24 Issue 4 (2013) 233 
ophthalmic drug delivery system (Ramesh et al., 
2009). Ribeiro et al. prepared and evaluated the 
polymeric micelles of single and mixed 
poloxamines (Tetronic) regarding their ability 
to host the antiglaucoma agent ethoxzolamide 
(ETOX) for topical ocular application. Three 
highly hydrophilic varieties of poloxamine 
(T908, T1107 and T1307) and a medium 
hydrophilic variety (T904), possessing a similar 
number of propylene oxide units but different 
contents in ethylene oxide, were chosen for the 
study. Micellar size ranged between 17 and 120 
nm and it was not altered after the loading of 
ETOX (2.7–11.5 mg drug g–1 poloxamine). 
Drug solubilization ability ranked in the order: 
T904 (50-fold increase in the apparent 
solubility) > T1107 ≈ T1307 >T908. Mixed 
micelles illustrated an intermediate capability to 
host ETOX but a greater physical stability, 
maintaining almost 100 per cent drug 
solubilized after 28 days. Furthermore, the 
different structural features of poloxamines and 
their combination in mixed micelles enabled 
the tuning of drug release profiles, sustaining 
the release in the 1–5 days range. These 
findings together with promising hen’s egg test-
chorioallantoic membrane biocompatibility 
tests make poloxamine micelles promising 
nanocarriers for carbonic anhydrase inhibitors 
in the treatment of glaucoma (Ribeiro et al., 
2012). 
 
Passive drug targeting to solid tumors 
Targeting of drugs to specific sites will 
successfully diminish adverse reactions as the 
action will be limited to cancer tissue only. 
Polymeric micelles can easily be functionalized 
to target specific types and may be promising 
delivery and imaging in the treatment of cancer 
(Dhembre et al., 2011). Passive targeting is 
defined as a method whereby the physical and 
chemical properties of carrier systems amplify 
the target/nontarget ratio of a quantity of a 
delivered drug. The passive targeting of 
polymeric micelles on solid tumors can be 
achieved owing to the enhanced permeability 
and retention effect (EPR effect) (Matsumura, 
2008). EPR effect can be viewed in almost all 
human cancers with the exception of 
hypovascular tumors such as prostate cancer or 
pancreatic cancer. For passive targeting to be 
successful, the PMs require to circulate in the 
blood for longer periods so that there will be 
multiple chances for the PMs to pass by the 
target site. Their size is known to play a 
significant role in achieving passive targeting 
and determining their biological fate. The hyper 
permeability of tumors associated with the EPR 
effect is based on excessive production and 
secretion of vascular permeability factors 
stimulating extravasation within cancerous 
tissue. Commonly secreted chemicals are 
vascular endothelial growth factor bradykinins, 
nitric oxide, 61 prostaglandins, enzyme 
collagenase, peroxynitrite (Matsumura, 2008). 
Currently, many drug-loaded polymeric 
micelles are under investigation for anticancer 
therapy in preclinical studies to improve drug 
efficacy. Five micellar formulations have been 
tested in clinical trials and they are presented in 
table III. 
 
Active drug targeting  
The goal of the active targeting is to 
augment the drugs delivery to the target sites by 
employing biologically specific interactions or 
by utilizing the heating and sonication i.e. 
locally applied signals (Matsumura, 2008). 
Specific interactions between the targeting 
components and antigens displayed on target 
tissues causes the selective amassing of drug in 
the target tissue. The active targeting can be 
achieved by molecular identification of the 
diseased cells by polymeric micelles, over 
expressed at the diseased site or via the ligand-
receptor or antigen-antibody interactions. 
Attachment of a ligand to the polymeric 
mielles’s surface increases cellular uptake 
through interaction between the ligand and its 
receptors which are over-expressed at the 
cancerous cell surface. The ligand involves 
pairing of Polymeric micelles with polymeric 
immunomicelles, epidermal growth factor 




Attachment of antibodies to micelle 
surface refers the largest opportunities in terms 
of variety of targets. Thus, many researchers 
have tried to develop this opportunity via 
covalently attaching an antibody to polymeric 
micelles for producing the 'immunomicelles' 
(Mourya et al., 2011). Recent studies have 
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verified that certain nonpathogenic mono-
clonal antinuclear autoantibodies with the 
nucleosome-restricted specificity (for instances 
mAb 2C5) can identify the surface of a range of 
different tumors and specifically connect to 
cancerous cells in vitro, but not normal cells by 
tumor cells surface-bound nucleosomes. 
Consequently, these antibodies serve as specific 
ligands for drug delivery and drug carriers into 
tumors. Torchillin (2009) reveal the efficacy of 
using immunomicelles in targeting of cancer by 
the solubilization of paclitaxel and 
camptothecin in mixed micelles of polyethylene 
glycol-phosphatidyl ethanolamine and vitamin 
E. These micelles were tailored with 
antinucleosome monoclonal antibody 2C5 
(mAb 2C5), which can particularly transport 
micelles to tumor cells in vitro. These mixed 
micelles and mAb 2C5-immunomicelles 
established significantly higher in vitro 
cytotoxicity against various cancer cell. 
 
CONCLUSION 
With the advent of nanotechnology, 
polymeric micelles have emerged as an 
important pharmaceutical carrier because of 
their attractive properties. As compared with 
the other novel drug delivery systems 
preparation of polymeric micelles appears to be 
relatively simple. Recently these carrier systems 
have been gathered much more considerable 
attention in the drug delivery, gene delivery and 
targeting field because of their high loading 
capacity for drug carrier as well as their unique 
disposition characteristics in the body. More 
importantly, the success of several thoroughly 
developed micellar formulations in clinical trials 
have paved the way for making polymer 
therapeutics based on other assemblies 
clinically   available.   At  the  same  time, much 
attention has been paid to polyion complex 
core-shell assemblies and non covalently 
connected polymeric assemblies for the delivery 
of the actives and genes. In every case, it is 
obvious that smart or intelligent drug delivery 
using the PMs will possibly bring the most 
facile, versatile, and efficient methodology in 
chemotherapy treatments for human diseases. 
Apart from it, fundamental research and the 
development of novel advanced polymeric 
micelles are ongoing. Thus, polymeric micelle 
based nanocarriers will continue to hold a 
promise for the delivery of drugs. 
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